Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (251-260 of 454) with videos related to

Pageof 46
Sort By:
BMC Nephrology|October 19, 2024
Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learningJohn W Larkin, Suman Lama, Sheetal Chaudhuri, et al.
The Annals of Occupational Hygiene|November 30, 2014
Comparison of ordinal and nominal classification trees to predict ordinal expert-based occupational exposure estimates in a case-control studyDavid C Wheeler, Kellie J Archer, Igor Burstyn, et al.
Diabetes, Obesity & Metabolism|March 28, 2023
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trialTae Won Yi, Michelle M Y Wong, Brendon L Neuen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE TrialSjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 6, 2022
Tobacco Retail Outlets, Neighborhood Deprivation and the Risk of Prenatal Smoke ExposureDavid C Wheeler, Joseph Boyle, D Jeremy Barsell, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.
American Journal of Nephrology|August 22, 2024
The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKDCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
Annals of Internal Medicine|December 5, 2022
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKDMeir Schechter, Niels Jongs, Glenn M Chertow, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 1, 2023
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of FrailtyPriya Vart, Jawad H Butt, Niels Jongs, et al.
Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.
Pageof 46

Showing results (251-260 of 454) with videos related to

Sort By:
Pageof 46
BMC Nephrology|October 19, 2024
Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learningJohn W Larkin, Suman Lama, Sheetal Chaudhuri, et al.
The Annals of Occupational Hygiene|November 30, 2014
Comparison of ordinal and nominal classification trees to predict ordinal expert-based occupational exposure estimates in a case-control studyDavid C Wheeler, Kellie J Archer, Igor Burstyn, et al.
Diabetes, Obesity & Metabolism|March 28, 2023
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trialTae Won Yi, Michelle M Y Wong, Brendon L Neuen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE TrialSjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 6, 2022
Tobacco Retail Outlets, Neighborhood Deprivation and the Risk of Prenatal Smoke ExposureDavid C Wheeler, Joseph Boyle, D Jeremy Barsell, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney DiseaseWilliam Herrington, Natalie Staplin, Parminder K Judge, et al.
American Journal of Nephrology|August 22, 2024
The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKDCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
Annals of Internal Medicine|December 5, 2022
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKDMeir Schechter, Niels Jongs, Glenn M Chertow, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 1, 2023
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of FrailtyPriya Vart, Jawad H Butt, Niels Jongs, et al.
Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.
Pageof 46